Ossiam Raises Stake in DaVita Inc. (NYSE:DVA)

Ossiam raised its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 71.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,105 shares of the company's stock after purchasing an additional 3,378 shares during the period. Ossiam's holdings in DaVita were worth $1,212,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. bought a new stake in shares of DaVita during the 4th quarter worth approximately $41,000. Canada Post Corp Registered Pension Plan bought a new stake in shares of DaVita during the fourth quarter worth $55,000. Venturi Wealth Management LLC increased its stake in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after buying an additional 152 shares during the period. Versant Capital Management Inc increased its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the period. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Up 0.5 %

Shares of DaVita stock traded up $0.71 during trading on Thursday, reaching $139.64. The company's stock had a trading volume of 648,254 shares, compared to its average volume of 839,940. The company has a 50-day simple moving average of $146.81 and a two-hundred day simple moving average of $155.40. DaVita Inc. has a 1-year low of $130.96 and a 1-year high of $179.60. The company has a market cap of $11.17 billion, a price-to-earnings ratio of 13.00, a P/E/G ratio of 1.07 and a beta of 1.04. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Thursday, April 10th. Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, DaVita presently has an average rating of "Hold" and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.